SCHEMBL14720705

SCHEMBL14720705

COC(=O)c1ccc(C=C2CCN(C3CCC3)CC2)c(Cl)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
KDM4E B2RXH2 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
ATM Q13315 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HRH3 Q9Y5N1 5/20 0.41
HSP90AA1 P07900 2/20 0.41
HSP90AB1 P08238 2/20 0.41
OPRL1 P41146 1/20 0.41
SRD5A2 P31213 1/20 0.40
TSHR P16473 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
OPRM1 P35372 1/20 0.39
OPRD1 P41143 1/20 0.39
OPRK1 P41145 1/20 0.39
OGFRL1 Q5TC84 1/20 0.39
LRRK2 Q5S007 1/20 0.38
FGFR1 P11362 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14720473 0.87 SRD5A2 (0.48) ALDH1A1KDM4ESMN1; SMN2ATMNPSR1
SCHEMBL14721173 0.83 LRRK2 (0.54) ALDH1A1KDM4EL3MBTL1HRH3LRRK2
SCHEMBL14720680 0.81 SRD5A2 (0.44) ALDH1A1KDM4EL3MBTL1HSP90AA1HSP90AB1
SCHEMBL14721178 0.78 HRH3 (0.43) ALDH1A1KDM4ESMN1; SMN2HRH3NPC1
SCHEMBL14720690 0.78 KMT2A (0.45) ALDH1A1KDM4EL3MBTL1SMN1; SMN2NPSR1
SCHEMBL14720751 0.76 HRH3 (0.52) ALDH1A1KDM4EL3MBTL1SMN1; SMN2HRH3
SCHEMBL1789885 0.76 HRH3 (0.62) HRH3OPRM1OPRD1OPRK1OGFRL1
SCHEMBL14721335 0.76 HRH3 (0.39) ALDH1A1KDM4EL3MBTL1NPSR1HRH3
SCHEMBL14720692 0.75 HRH3 (0.40) HRH3SRD5A2
SCHEMBL12497138 0.74 ALDH1A1 (0.43) ALDH1A1KDM4EL3MBTL1SMN1; SMN2HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed